恒溫核酸增幅技術市場規模、佔有率和成長分析：按技術、產品、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球恒溫核酸增幅技術市場價值為 47 億美元，預計到 2025 年將成長至 50.4 億美元，到 2033 年將成長至 88.6 億美元，在預測期（2026-2033 年）內複合年成長率為 7.3%。

全球恒溫核酸增幅技術市場專注於在DNA和RNA複製過程中保持恆溫的方法，因此無需使用PCR中常用的熱迴圈儀。這項技術能夠實現快速、便攜的分子檢測，對感染疾病監測、食品安全和腫瘤學應用至關重要。在即時診斷需求激增的推動下（尤其是在健康危機期間），該市場正隨著數位健康平台的整合而不斷發展，這些平台增強了技術的擴充性和分析能力。因此，檢測結果可在數分鐘內獲得，與行動應用程式和電子健康記錄的整合也更加便捷，並且能夠進行有效的流行病學追蹤。此外，人工智慧驅動的自動化正在改善檢測設計和操作效率，推動新興市場加強投資和普及，最終加速市場成長並豐富醫療保健解決方案。

全球恒溫核酸增幅技術市場的成長要素

臨床和現場環境中對快速病原體檢測的需求日益成長，推動了恒溫核酸增幅技術的應用。此方法非常適合即時檢測，因為它只需幾分鐘即可獲得結果，且無需複雜的循環反應。顯著縮短檢測時間有助於及時制定治療方案，改善患者預後，並提高營運效率。因此，這種速度優勢正促使檢查室、醫院和行動檢測機構將等溫擴增技術整合到診斷流程中，使全球各類醫療保健系統和公共衛生計畫受益。

全球恒溫核酸增幅技術市場面臨的限制因素

恒溫核酸增幅設備、耗材及相關軟體的高昂初始投資對新興市場的小規模檢查室和醫療機構構成重大障礙。這項經濟門檻限制了他們在不大幅調整預算或尋求外部資金的情況下採用該技術的能力，可能阻礙成本敏感地區的早期應用，並減緩市場成長。因此，儘管等溫平台具有許多優勢，潛在買家可能更傾向於選擇價格較低的傳統PCR方法。此外，對投資報酬率和持續維護成本的擔憂也導致他們不願意採用該技術，從而延長了市場滲透過程。

恒溫核酸增幅技術的全球市場趨勢

全球恒溫核酸增幅技術市場正經歷著向即時診斷的顯著轉變，從根本上改變了醫療服務的提供方式。該技術固有的簡便性、快速出結果和對設備要求極低等特點，正促使醫療專業人員使用攜帶式檢測套組進行高效的傳染病篩檢。因此，對中心檢查室的依賴性大幅降低，使得在各種醫療環境中都能快速做出決策。這種需求的激增推動了生物技術公司和即時診斷設備製造商之間的合作，從而催生了方便用戶使用型、電池供電平台的創新，尤其是在新興市場等資源匱乏的環境中。最終，這將改善全球患者照護效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球恒溫核酸增幅技術市場規模：依技術分類

• 恒溫環型核酸擴增（LAMP）
• 重組酶聚合酵素擴增法（RPA）
• 解旋酶依賴性擴增（HDA）
• 核酸序列擴增（NASBA）
• 鏈置換擴增（SDA）
• 滾動循環放大器（RCA）
• 其他等溫放大技術

全球恒溫核酸增幅技術市場規模：依產品分類。

• 試劑和試劑盒
• 儀器/分析儀
• 消耗品
• 軟體服務

全球恒溫核酸增幅技術市場規模：依應用領域分類

• 傳染病檢查
• 腫瘤檢查
• 遺傳疾病和罕見疾病檢測
• 血液篩檢
• 食品安全檢查
• 獸醫診斷
• 環境測試
• 其他用途

全球恒溫核酸增幅技術市場規模：依最終用戶分類

• 醫院/診斷檢查室
• 學術研究機構
• 製藥和生物技術公司
• 即時檢測中心
• 食品飲料檢驗實驗室
• 獸醫醫院和檢測實驗室
• 其他最終用戶

全球恒溫核酸增幅技術市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Eiken Chemical Co., Ltd.
• Meridian Bioscience, Inc.
• BioMerieux SA
• QIAGEN NV
• TwistDx Limited
• New England Biolabs, Inc.
• OptiGene Limited
• HiberGene Diagnostics Limited
• Mast Group Ltd.
• Genomtec SA
• Atila BioSystems, Inc.
• Ustar Biotechnologies Ltd.
• Tianlong Science and Technology Co., Ltd.
• Sansure Biotech Inc.
• Bioneer Corporation
• Sysmex Corporation
• Fujirebio Holdings, Inc.
• Coris BioConcept
• QuantuMDx Group Limited

結論與建議

Global Isothermal Nucleic Acid Amplification Technology Market size was valued at USD 4.7 Billion in 2024 and is poised to grow from USD 5.04 Billion in 2025 to USD 8.86 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global market for isothermal nucleic acid amplification technology focuses on consistent-temperature methods for DNA and RNA replication, eliminating the need for thermocyclers typically employed in PCR. This technology enables rapid, portable molecular testing, essential for infectious disease monitoring, food safety, and oncology applications. Driven by a surging demand for point-of-care diagnostics, particularly highlighted during health crises, the market is evolving with the integration of digital health platforms that enhance scalability and analytics. Consequently, tests yield results in minutes, facilitating connections to mobile apps and electronic health records for effective epidemiological tracking. Additionally, AI-driven automation is enhancing assay design and operational efficiency, prompting increased investments and adoption in emerging markets, ultimately propelling market growth and enriching healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Isothermal Nucleic Acid Amplification Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Isothermal Nucleic Acid Amplification Technology Market Segments Analysis

Global isothermal nucleic acid amplification technology market is segmented by technology, product, application, end user and region. Based on technology, the market is segmented into Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), Helicase-Dependent Amplification (HDA), Nucleic Acid Sequence-Based Amplification (NASBA), Strand Displacement Amplification (SDA), Rolling Circle Amplification (RCA) and Other Isothermal Amplification Technologies. Based on product, the market is segmented into Reagents & Kits, Instruments & Analyzers, Consumables and Software & Services. Based on application, the market is segmented into Infectious Disease Testing, Oncology Testing, Genetic & Rare Disease Testing, Blood Screening, Food Safety Testing, Veterinary Diagnostics, Environmental Testing and Other Applications. Based on end user, the market is segmented into Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Point-of-Care Testing Centers, Food & Beverage Testing Laboratories, Veterinary Clinics & Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Isothermal Nucleic Acid Amplification Technology Market

The growing demand for rapid pathogen detection in both clinical and field environments is driving the adoption of isothermal nucleic acid amplification technology. This method provides results in just minutes and eliminates the need for complicated thermal cycling, making it suitable for point-of-care testing. By significantly reducing turnaround times, it facilitates timely therapeutic decisions that enhance patient outcomes and boost operational efficiency. As a result, this speed advantage encourages laboratories, hospitals, and mobile testing units to incorporate isothermal amplification into their diagnostic workflows, thereby benefiting diverse healthcare systems and public health initiatives worldwide.

Restraints in the Global Isothermal Nucleic Acid Amplification Technology Market

The high initial investment required for isothermal nucleic acid amplification instruments, consumables, and associated software creates a significant barrier for small laboratories and healthcare providers in emerging markets. This financial hurdle restricts their capacity to implement the technology without substantial budget adjustments or outside funding, which can hinder early adoption and slow market growth in cost-sensitive areas. As a result, potential buyers may lean towards more affordable traditional PCR methods, despite the advantages offered by isothermal platforms. Furthermore, apprehensions regarding return on investment and ongoing maintenance costs contribute to the reluctance to adopt, lengthening the process for market integration.

Market Trends of the Global Isothermal Nucleic Acid Amplification Technology Market

The Global Isothermal Nucleic Acid Amplification Technology market is witnessing a significant trend towards the adoption of point-of-care diagnostics, fundamentally transforming healthcare delivery. This technology's inherent simplicity, rapid results, and minimal equipment needs are compelling healthcare professionals to utilize portable testing kits for efficient infectious disease screening. As a result, there is a notable decrease in dependence on centralized laboratories, allowing for rapid decision-making in diverse healthcare settings. The surge in demand has spurred collaborations between biotechnology companies and point-of-care device manufacturers, leading to the innovation of user-friendly, battery-operated platforms that cater to low-resource environments, particularly in emerging markets, ultimately enhancing patient care outcomes globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Isothermal Nucleic Acid Amplification Technology Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Loop-Mediated Isothermal Amplification (LAMP)
• Recombinase Polymerase Amplification (RPA)
• Helicase-Dependent Amplification (HDA)
• Nucleic Acid Sequence-Based Amplification (NASBA)
• Strand Displacement Amplification (SDA)
• Rolling Circle Amplification (RCA)
• Other Isothermal Amplification Technologies

Global Isothermal Nucleic Acid Amplification Technology Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Kits
• Instruments & Analyzers
• Consumables
• Software & Services

Global Isothermal Nucleic Acid Amplification Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Genetic & Rare Disease Testing
• Blood Screening
• Food Safety Testing
• Veterinary Diagnostics
• Environmental Testing
• Other Applications

Global Isothermal Nucleic Acid Amplification Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Point-of-Care Testing Centers
• Food & Beverage Testing Laboratories
• Veterinary Clinics & Laboratories
• Other End Users

Global Isothermal Nucleic Acid Amplification Technology Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End User)
  • US
  • Canada
• Europe (Technology, Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eiken Chemical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TwistDx Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiGene Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiberGene Diagnostics Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mast Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomtec S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atila BioSystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ustar Biotechnologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianlong Science and Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sansure Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coris BioConcept
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations